Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/16/2010WO2010143052A1 Novel pharmaceutical compositions containing pregabalin
12/16/2010WO2010143020A1 Therapeutical use of ternary complexes of valproic acid
12/16/2010WO2010143006A1 Orally bioavailable iron chelators in the treatment of an inflammatory bowel disease
12/16/2010WO2010142996A1 Therapeutic agent and assay
12/16/2010WO2010142994A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
12/16/2010WO2010142985A1 Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
12/16/2010WO2010142978A1 Heterocyclic urea derivatives and methods of use thereof
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142925A1 Use of alkylglycerols for preparing drugs
12/16/2010WO2010142890A1 Composition including a molecule promoting the neuron-glia interaction, in particular for preventing the formation of the glial scar and inducing neural regeneration
12/16/2010WO2010142827A1 5'-methylthioadenosine neuroprotective properties
12/16/2010WO2010142814A1 Reduction of opioid blood fluctuations
12/16/2010WO2010142805A1 New potent anti apob antisense compounds
12/16/2010WO2010142801A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010WO2010142779A1 Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
12/16/2010WO2010142761A1 The succinate of tenofovir disoproxil
12/16/2010WO2010142752A1 Janus kinase inhibitor compounds and methods
12/16/2010WO2010142750A1 Niacin and/or trigonelline as a muscle stimulant
12/16/2010WO2010142741A1 Phenylpyridylpyridones for use as antimalarial agents
12/16/2010WO2010142739A1 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
12/16/2010WO2010142735A1 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010WO2010142705A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/16/2010WO2010142696A1 Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
12/16/2010WO2010142663A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
12/16/2010WO2010142656A1 Heterocyclic antiviral compounds
12/16/2010WO2010142652A1 Imidazobenzazepine compounds for the treatment of central nervous system (cns) diseases
12/16/2010WO2010142650A1 Novel cyclopentane derivatives
12/16/2010WO2010142642A1 4 -hydrazono- 1,4 -dihydropyridine derivatives for the treatment of neurodegenerative diseases
12/16/2010WO2010142628A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010WO2010142603A1 Screening for compounds that modulate gpr3-mediated beta-arrestin signaling and amyloid beta peptide generation
12/16/2010WO2010142504A1 Dry whole milk preparations containing probiotic micro-organisms
12/16/2010WO2010142457A1 Semi-solid compositions and pharmaceutical products
12/16/2010WO2010142456A1 Solid compositions comprising 5-aminolevulinic acid
12/16/2010WO2010142426A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010WO2010142402A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010WO2010142241A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
12/16/2010WO2010142216A1 PYRAZOLO-[1,5-a]-PYRIMIDONES DERIVATES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
12/16/2010WO2010142183A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010142182A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010142167A1 New use of carboxyamidotriazole compounds or salts thereof in the preparation of the medicaments for preventing and treating interstitial pneumonia or pulmonary fibrosis
12/16/2010WO2010142143A1 Pirfenidone compound, preparation method and use thereof
12/16/2010WO2010142137A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/16/2010WO2010142124A1 New uses of medicines with adamantane structure and their derivatives and analogues in treating tumor-related diseases
12/16/2010WO2010142027A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010WO2010142007A1 Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
12/16/2010WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor
12/16/2010WO2010124089A3 Nepicastat for treating dependence
12/16/2010WO2010123221A9 Composition for preventing and improving the symptoms of menopause, containing glyceollins as an active ingredient
12/16/2010WO2010122580A3 Piperidine derivatives as inhibitors of renin
12/16/2010WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
12/16/2010WO2010115751A3 Oxadiazole derivatives
12/16/2010WO2010111136A3 Aliskiren modulation of neurogenesis
12/16/2010WO2010107329A3 Aripiprazole salts
12/16/2010WO2010102778A3 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
12/16/2010WO2010100656A3 Storage stable prostaglandin product
12/16/2010WO2010100404A3 Rna molecules and therapeutic uses thereof
12/16/2010WO2010096551A3 Antimicrobial compositions
12/16/2010WO2010093890A3 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides
12/16/2010WO2010091124A3 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
12/16/2010WO2010083241A3 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
12/16/2010WO2010071852A3 Oligonucleotide micelles
12/16/2010WO2010060886A3 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient
12/16/2010WO2010055474A3 Antimicrobial compounds and compositions
12/16/2010WO2010025558A8 Triazolium and imidazolium salts and uses thereof
12/16/2010WO2010018278A3 Composition of dialysis liquid comprising crystallisation inhibitor substances
12/16/2010WO2010007252A3 Formulation for improving the bioavailability of a hydrophobic molecule
12/16/2010WO2010006342A9 Compositions and methods for inhibiting expression of gsk-3 genes
12/16/2010WO2010005557A3 Biological therapeutic compositions and methods thereof
12/16/2010WO2009144555A8 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/16/2010WO2009134973A8 Quinolines and related analogs as sirtuin modulators
12/16/2010US20100319074 Multi-targeted rnai therapeutics for scarless wound healing of skin
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100318040 Catheter Locking Solution Having Antimicrobial and Anticoagulation Properties
12/16/2010US20100318003 Method and Apparatus for Connective Tissue Treatment
12/16/2010US20100317865 Enzyme and receptor modulation
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317741 Method for treating septic shock or endotoxemia
12/16/2010US20100317740 Method for Predicting Response to Tamoxifen
12/16/2010US20100317739 Histone deacetylase inhibitors
12/16/2010US20100317738 Compositions and methods for treating conditions associated with neuronal dysfunction
12/16/2010US20100317737 Topical delivery of l-arginine to cause beneficial effects
12/16/2010US20100317735 High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
12/16/2010US20100317734 Free fatty acid blends and use thereof
12/16/2010US20100317733 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils
12/16/2010US20100317732 Method of inhibiting abcg2 and other treatment methods
12/16/2010US20100317731 Hyperhidrosis treatment
12/16/2010US20100317730 Treatment for menopausal and perimenopausal vasomotor symptons
12/16/2010US20100317729 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
12/16/2010US20100317728 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses
12/16/2010US20100317727 Rosemary extracts, dietary and pharmaceutical compostions containing them and their uses
12/16/2010US20100317726 Slco1b3 genotype
12/16/2010US20100317725 Choline Esters
12/16/2010US20100317723 Nucleolin Specific Aptamer and Use thereof
12/16/2010US20100317722 NUCLEIC ACID SEQUENCES COMPRISING NF-kB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
12/16/2010US20100317721 Compositions and Methods for Treating Tumors, Fibrosis, and Pulmonary Alveolar Proteinosis
12/16/2010US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions
12/16/2010US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field
12/16/2010US20100317718 Modulation of hif1 beta expression
12/16/2010US20100317717 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/16/2010US20100317716 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
1 ... 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 ... 7860